TSC2 and tuberous sclerosis: In 2012, the Tuberous Sclerosis Complex Surveillance and Management recommendations were updated to include the identification of a heterozygous pathogenic variant in either TSC1 or TSC2 by molecular genetic testing as meeting criteria for a definitive diagnosis of TSC.